NasdaqGS - Nasdaq Real Time Price USD
LAVA Therapeutics N.V. (LVTX)
1.3208
-0.0392
(-2.88%)
As of 3:24:11 PM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
80,831
101,673
143,425
139,247
Total Liabilities Net Minority Interest
53,086
50,309
57,385
20,880
Total Equity Gross Minority Interest
27,745
51,364
86,040
118,367
Total Capitalization
27,745
51,364
86,040
122,651
Common Stock Equity
27,745
51,364
86,040
118,367
Capital Lease Obligations
395
830
810
581
Net Tangible Assets
27,745
51,364
86,040
118,367
Working Capital
61,291
84,003
118,579
125,257
Invested Capital
32,631
56,646
90,680
122,651
Tangible Book Value
27,745
51,364
86,040
118,367
Total Debt
5,281
6,112
5,450
4,865
Share Issued
26,305.2950
26,289.0870
26,289.0870
25,775.5380
Ordinary Shares Number
26,305.2950
26,289.0870
26,289.0870
25,775.5380
12/31/2021 - 3/26/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HLVX HilleVax, Inc.
1.9500
-4.41%
IKNA Ikena Oncology, Inc.
1.4600
-0.68%
PMVP PMV Pharmaceuticals, Inc.
1.1800
+11.21%
EPIX ESSA Pharma Inc.
1.7100
+0.58%
ANTX AN2 Therapeutics, Inc.
1.1150
-0.45%
KZR Kezar Life Sciences, Inc.
4.7100
+5.83%
SYBX Synlogic, Inc.
1.2946
+2.34%
TBPH Theravance Biopharma, Inc.
10.78
-1.55%
CRGX CARGO Therapeutics, Inc.
4.5800
-1.29%
NERV Minerva Neurosciences, Inc.
1.8100
-1.63%